ID

41036

Descripción

A Phase II Study of Dasatinib in Children and Adolescents With Newly Diagnosed Chronic Phase CML or With Ph+ Leukemias Resistant or Intolerant to Imatinib; ODM derived from: https://clinicaltrials.gov/show/NCT00777036

Link

https://clinicaltrials.gov/show/NCT00777036

Palabras clave

Versiones (1)
  1. 16/6/20 16/6/20 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

16 de junio de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Leukemia NCT00777036

Inglés

Eligibility Leukemia NCT00777036

1 formularios  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00777036
Criteria
Descripción

Criteria

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
cp-cml who prove resistant or intolerant to imatinib (cohort #1)
Descripción

Leukemia, Myeloid, Chronic-Phase | Resistant to Imatinib | Intolerance to Imatinib

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023474
UMLS CUI [2,1]
C0332325
UMLS CUI [2,2]
C0935989
UMLS CUI [3,1]
C1744706
UMLS CUI [3,2]
C0935989
ph+ all, ap-cml, or bp-cml who are resistant or intolerant to or who relapse after imatinib therapy (cohort #2)
Descripción

Philadelphia positive acute lymphocytic leukaemia | Leukemia, Myeloid, Accelerated Phase | Blast Phase | Resistant to Imatinib | Intolerance to Imatinib | Relapse | Status post Imatinib

Tipo de datos

boolean

Alias
UMLS CUI [1]
C4524071
UMLS CUI [2]
C0023472
UMLS CUI [3]
C0005699
UMLS CUI [4,1]
C0332325
UMLS CUI [4,2]
C0935989
UMLS CUI [5,1]
C1744706
UMLS CUI [5,2]
C0935989
UMLS CUI [6]
C0035020
UMLS CUI [7,1]
C0231290
UMLS CUI [7,2]
C0935989
newly diagnosed, treatment naive cp-cml (cohort #3)
Descripción

Therapy naive | Chronic-Phase Myeloid Leukemia Newly Diagnosed

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0919936
UMLS CUI [2,1]
C0023474
UMLS CUI [2,2]
C1518321
lansky or karnofsky scale >50
Descripción

Lansky Play-Performance Status | Karnofsky Performance Status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1522275
UMLS CUI [2]
C0206065
life expectancy ≥12 weeks
Descripción

Life Expectancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023671
adequate hepatic and renal function
Descripción

Liver function | Renal function

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C0232804
written informed consent
Descripción

Informed Consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
eligibility for potentially-curative therapy including hematopoietic stem-cell transplantation
Descripción

Eligibility Curative treatment | Eligibility Hemopoietic stem cell transplant

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1548635
UMLS CUI [1,2]
C1273390
UMLS CUI [2,1]
C1548635
UMLS CUI [2,2]
C0472699
symptomatic cns involvement (other than signs and symptoms caused by leptomeningeal disease)
Descripción

Central Nervous System Involvement Symptomatic | Exception Signs and Symptoms caused by Leptomeningeal disease

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C4050309
UMLS CUI [1,2]
C0231220
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0037088
UMLS CUI [2,3]
C0015127
UMLS CUI [2,4]
C0751297
isolated extramedullary disease
Descripción

Disease Extramedullary Isolated

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C1517060
UMLS CUI [1,3]
C0205409
prior therapy with dasatinib
Descripción

Prior Therapy Dasatinib

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C1455147
Volver a la parte superior de la página

Similar models

Eligibility Leukemia NCT00777036

1 formularios
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00777036
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Item Group
C1512693 (UMLS CUI)
Leukemia, Myeloid, Chronic-Phase | Resistant to Imatinib | Intolerance to Imatinib
Item
cp-cml who prove resistant or intolerant to imatinib (cohort #1)
boolean
C0023474 (UMLS CUI [1])
C0332325 (UMLS CUI [2,1])
C0935989 (UMLS CUI [2,2])
C1744706 (UMLS CUI [3,1])
C0935989 (UMLS CUI [3,2])
Philadelphia positive acute lymphocytic leukaemia | Leukemia, Myeloid, Accelerated Phase | Blast Phase | Resistant to Imatinib | Intolerance to Imatinib | Relapse | Status post Imatinib
Item
ph+ all, ap-cml, or bp-cml who are resistant or intolerant to or who relapse after imatinib therapy (cohort #2)
boolean
C4524071 (UMLS CUI [1])
C0023472 (UMLS CUI [2])
C0005699 (UMLS CUI [3])
C0332325 (UMLS CUI [4,1])
C0935989 (UMLS CUI [4,2])
C1744706 (UMLS CUI [5,1])
C0935989 (UMLS CUI [5,2])
C0035020 (UMLS CUI [6])
C0231290 (UMLS CUI [7,1])
C0935989 (UMLS CUI [7,2])
Therapy naive | Chronic-Phase Myeloid Leukemia Newly Diagnosed
Item
newly diagnosed, treatment naive cp-cml (cohort #3)
boolean
C0919936 (UMLS CUI [1])
C0023474 (UMLS CUI [2,1])
C1518321 (UMLS CUI [2,2])
Lansky Play-Performance Status | Karnofsky Performance Status
Item
lansky or karnofsky scale >50
boolean
C1522275 (UMLS CUI [1])
C0206065 (UMLS CUI [2])
Life Expectancy
Item
life expectancy ≥12 weeks
boolean
C0023671 (UMLS CUI [1])
Liver function | Renal function
Item
adequate hepatic and renal function
boolean
C0232741 (UMLS CUI [1])
C0232804 (UMLS CUI [2])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Eligibility Curative treatment | Eligibility Hemopoietic stem cell transplant
Item
eligibility for potentially-curative therapy including hematopoietic stem-cell transplantation
boolean
C1548635 (UMLS CUI [1,1])
C1273390 (UMLS CUI [1,2])
C1548635 (UMLS CUI [2,1])
C0472699 (UMLS CUI [2,2])
Central Nervous System Involvement Symptomatic | Exception Signs and Symptoms caused by Leptomeningeal disease
Item
symptomatic cns involvement (other than signs and symptoms caused by leptomeningeal disease)
boolean
C4050309 (UMLS CUI [1,1])
C0231220 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0037088 (UMLS CUI [2,2])
C0015127 (UMLS CUI [2,3])
C0751297 (UMLS CUI [2,4])
Disease Extramedullary Isolated
Item
isolated extramedullary disease
boolean
C0012634 (UMLS CUI [1,1])
C1517060 (UMLS CUI [1,2])
C0205409 (UMLS CUI [1,3])
Prior Therapy Dasatinib
Item
prior therapy with dasatinib
boolean
C1514463 (UMLS CUI [1,1])
C1455147 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial